Voyager Therapeutics, Inc. (VYGR)

CIK 1640266 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Voyager Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-449719
Nov 5, 20268-K0001193125-26-449728
Nov 3, 202640001193125-26-445317
Nov 3, 202640001193125-26-445316
Oct 21, 20268-K0001193125-26-427224
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003626
Aug 6, 202610-Q0001640266-26-000006
Aug 6, 20268-K0001640266-26-000007
Jul 31, 2026SCHEDULE 13G/A0001104659-26-089311
Jul 13, 20268-K0001104659-26-082906
Jun 11, 202640001104659-26-072922
Jun 11, 202640001104659-26-072919
Jun 11, 202640001104659-26-072924
Jun 11, 202640001104659-26-072917
Jun 11, 202640001104659-26-072921
Jun 11, 202640001104659-26-072927
Jun 11, 202640001104659-26-072923
Jun 11, 202640001104659-26-072934
Jun 11, 202640001104659-26-072926
Jun 10, 20268-K0001104659-26-072324
Jun 1, 20268-K0001104659-26-068591
May 18, 202630001104659-26-063176
May 15, 2026SCHEDULE 13G/A0001172661-26-002122
May 15, 2026SCHEDULE 13G/A0000935836-26-000263
May 15, 20261440001959173-26-003638